Genprex Inc (GNPX)

Oct 15, 2025

What institutional flow reveals about Genprex Inc.Portfolio Gains Summary & Target Return Focused Stock Picks - newser.com

Oct 15, 2025

Oct 15, 2025

Key metrics from Genprex Inc.’s quarterly dataGap Up & Free High Accuracy Swing Entry Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Will Genprex Inc. stock deliver consistent dividendsPortfolio Return Report & Low Risk High Win Rate Picks - newser.com

Oct 15, 2025

Oct 15, 2025

Gene Therapy Stock Genprex, Inc. (NASDAQ: GNPX) Makes Nasdaq Top Gainers List on News of Positive Preclinical Data on the Use of Reqorsa - Investorideas.com

Oct 15, 2025

Oct 15, 2025

Genprex (GNPX) Stock Soars on Lung Cancer Gene Therapy Data - parameter.io

Oct 15, 2025

Oct 15, 2025

Evaluating Genprex Inc. with trendline analysisTrade Performance Summary & Precise Swing Trade Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Genprex (NASDAQ:GNPX) Stock Skyrockets 40% on Lung Cancer Gene Therapy Breakthrough - ts2.tech

Oct 15, 2025

Oct 15, 2025

Genprex (GNPX) Shares Jump 41% After Hours Following New Cancer Therapy Data - Benzinga

Oct 15, 2025

Oct 15, 2025

Why Genprex Inc. stock is popular among millennialsWeekly Trend Recap & Real-Time Buy Signal Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

How Genprex Inc. stock responds to policy changesEarnings Recap Report & Verified Chart Pattern Signals - newser.com

Oct 15, 2025

Oct 15, 2025

Is now a turning point for Genprex Inc.Weekly Trend Report & Entry Point Strategy Guides - newser.com

Oct 15, 2025

Oct 14, 2025

Pre-market Movers: GNPX, BFRI, DBVT See Big Swings - RTTNews

Oct 14, 2025

Oct 14, 2025

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics - Star Local Media

Oct 14, 2025

Oct 14, 2025

Using portfolio simulators with Genprex Inc. includedMarket Risk Summary & Technical Buy Zone Confirmations - newser.com

Oct 14, 2025

Oct 13, 2025

How to forecast Genprex Inc. trends using time seriesPortfolio Return Report & AI Powered Trade Plan Recommendations - newser.com

Oct 13, 2025

Oct 09, 2025

Heatmap analysis for Genprex Inc. and competitorsJuly 2025 Catalysts & Growth Focused Entry Point Reports - newser.com

Oct 09, 2025

Oct 09, 2025

What to expect from Genprex Inc. in the next 30 daysJuly 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com

Oct 09, 2025

Oct 09, 2025

Is Genprex Inc. still worth holding after the dipQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com

Oct 09, 2025

Oct 06, 2025

How high can Genprex Inc. stock goMarket Movers & Growth Focused Stock Pick Reports - newser.com

Oct 06, 2025

Oct 06, 2025

Can Genprex Inc. stock resist market sell offsJuly 2025 Outlook & Long-Term Investment Growth Plans - newser.com

Oct 06, 2025

Oct 06, 2025

Is Genprex Inc. (2DE0) stock a top hedge fund pickTrade Entry Report & High Conviction Trade Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Analyzing net buyer seller activity in Genprex Inc.2025 Sector Review & Growth Oriented Trade Recommendations - newser.com

Oct 05, 2025

Oct 03, 2025

Risk vs reward if holding onto Genprex Inc.Market Volume Summary & Expert Curated Trade Setups - newser.com

Oct 03, 2025

Sep 30, 2025

Non-Viral Transfection Reagents Industry Report 2025, with Profiles of Altogen Biosystems, BEX, BTX, Celsion, Genprex, Inovio Pharmaceuticals, MaxCyte, MilliporeSigma, Nepa Gene, OZ Biosciences & MoreResearchAndMarkets.com - FinancialContent

Sep 30, 2025

Sep 30, 2025

Is Genprex Inc a good long term investmentDividend Stock Watch & Superior Wealth Strategies - earlytimes.in

Sep 30, 2025

Sep 28, 2025

What analysts say about Genprex Inc stockRetail Investor Activity & Invest Now – Opportunity Window Closing - earlytimes.in

Sep 28, 2025

Sep 27, 2025

What drives Genprex Inc 2DE0 stock priceIPO Market Watch & Claim Your Custom Stock Report Now - earlytimes.in

Sep 27, 2025